Nursing facility
Meridian Hospitals Corporation
Meridian Hospitals Corporation was paid $2.88M by Medicaid between Jan 2018 and Sep 2018, across 128 billing codes. Its largest line is G0378, Hospital observation service, per hour — 21% of everything it billed.
33Billing provider infoMERIDIAN HOSPITALS CORPORATION
HOLMDEL, NJ 07733
HOLMDEL, NJ 07733
33aNPI1831197508assigned 07/07/2005
33bProvider typeAssisted Living Facility
28Total paid$2.88M
24GClaims42,811
24DCodes billed128
24AFirst – last monthJan 2018 – Sep 2018
Compared with peers
Next to other Assisted Living Facility providers in New Jersey
Rank by total paid#34 of 167
Median peer was paid$954K
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,811 | $2.88M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0378 | Hospital observation service, per hour | 21% | 780 | 720 | $613K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 1,554 | 1,495 | $479K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 1,221 | 1,149 | $466K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.7% | 927 | 884 | $194K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.7% | 811 | 788 | $165K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.8% | 1,176 | 330 | $138K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 4.5% | 113 | 113 | $129K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.0% | 125 | 125 | $85K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.7% | 764 | 220 | $49K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.6% | 41 | 41 | $45K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 2,780 | 2,212 | $30K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.0% | 313 | 307 | $29K |
116 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,486 | $27K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,320 | $25K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 433 | $19K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 22 | $17K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,274 | $15K |
| OP259 | <1% | 2,813 | $15K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 368 | $15K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 205 | $14K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 487 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,042 | $13K |
| 97010 | <1% | 883 | $12K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 103 | $12K |
| OP272 | <1% | 476 | $10K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 194 | $10K |
| 97161 | <1% | 88 | $10K | |
| 80053 | Comprehensive metabolic panel | <1% | 622 | $10K |
| 85610 | <1% | 588 | $9K | |
| 80076 | <1% | 1,266 | $9K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 570 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 382 | $8K |
| 84484 | <1% | 860 | $8K | |
| 71045 | Radiologic examination, chest; single view | <1% | 279 | $7K |
| 85730 | <1% | 510 | $7K | |
| 81003 | <1% | 1,242 | $7K | |
| OP279 | <1% | 361 | $7K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 682 | $7K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 442 | $6K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 148 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 439 | $6K |
| 93971 | <1% | 74 | $6K | |
| 77066 | Tomosynthesis, mammo | <1% | 39 | $6K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 40 | $5K |
| J2704 | Injection, propofol, 10 mg | <1% | 179 | $5K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 88 | $4K |
| OP379 | <1% | 224 | $4K | |
| 83690 | <1% | 716 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 216 | $4K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 89 | $4K |
| 76830 | Ultrasound, transvaginal | <1% | 65 | $3K |
| 83880 | <1% | 111 | $3K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 28 | $3K |
| 80061 | Lipid panel | <1% | 211 | $3K |
| 73562 | <1% | 161 | $3K | |
| 86885 | <1% | 119 | $3K | |
| 86900 | <1% | 131 | $3K | |
| 86901 | <1% | 131 | $3K | |
| 85027 | <1% | 351 | $3K | |
| 82150 | <1% | 240 | $2K | |
| 96376 | <1% | 195 | $2K | |
| OP710 | <1% | 183 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 86 | $2K |
| 83735 | <1% | 199 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 22 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 295 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 91 | $2K |
| 87186 | <1% | 30 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 173 | $2K |
| 87070 | <1% | 347 | $2K | |
| 72110 | <1% | 38 | $2K | |
| 73630 | <1% | 140 | $2K | |
| 97162 | <1% | 51 | $2K | |
| 87088 | <1% | 307 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 444 | $1K |
| 88300 | <1% | 25 | $1K | |
| 93970 | <1% | 14 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 99 | $1K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 84 | $1K |
| 84100 | <1% | 110 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 43 | $1K |
| 87040 | <1% | 123 | $1K | |
| 73130 | <1% | 79 | $1K | |
| 73610 | <1% | 122 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 225 | $1K |
| 96367 | <1% | 17 | $1K | |
| 72100 | <1% | 81 | $1K | |
| 73030 | <1% | 96 | $1K | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 16 | $1K |
| 82607 | <1% | 41 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 442 | $1K |
| 84703 | <1% | 662 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 86 | $828.68 |
| 87205 | <1% | 69 | $770.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 14 | $758.30 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 121 | $728.02 |
| 83789 | <1% | 80 | $675.02 | |
| 82746 | <1% | 12 | $633.47 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 44 | $553.07 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 46 | $553.07 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 467 | $486.09 |
| 76775 | <1% | 14 | $452.52 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 284 | $449.46 |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 18 | $403.56 |
| 72040 | <1% | 42 | $383.63 | |
| 90715 | <1% | 43 | $378.72 | |
| 81025 | <1% | 225 | $340.33 | |
| 83605 | <1% | 39 | $312.49 | |
| 85378 | <1% | 216 | $299.22 | |
| 73502 | <1% | 28 | $291.99 | |
| 73110 | <1% | 13 | $290.18 | |
| 84702 | <1% | 57 | $193.02 | |
| 84439 | <1% | 18 | $190.28 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 68 | $151.58 |
| 88313 | <1% | 110 | $134.25 | |
| 74021 | <1% | 14 | $33.35 | |
| 86308 | <1% | 13 | $32.90 | |
| 87999 | <1% | 38 | $31.20 | |
| 85651 | <1% | 12 | $27.54 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 47 | $17.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 41 | $15.52 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 63 | $9.00 |
| J1956 | Injection, levofloxacin, 250 mg | <1% | 18 | $8.20 |
| 88312 | <1% | 103 | $6.38 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 15 | $3.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 17 | $0.00 |
| 88304 | 0% | 17 | $0.00 | |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKOCZAN, MARILYN (VP - FINANCE)